BioSpace News Archive

Clyra Medical Technologies Also Joins Forces with Powerplay Retail to Ensure Broad Availability of Revolutionary Product to Safeguard Against Airborne Viruses [13-October-2020] TAMPA, Fla., Oct. 13, 2020 /PRNewswire/ -- Just in time for Amazon Prime Day, Clyra Medical Technologies, a med-tech company with deep experience fighting hospital-acquired infections, has annou

Seymour brings extensive experience in driving value-based arrangements through collaborative partnerships with providers to improve patient health and make care more affordable p

Scott Thomson has been appointed CEO of SPI Pharma. A highly experienced international business executive with a proven track record in strategy development and execution, operational management, and innovation for Specialty Ingredients, Scott joins SPI Pharma after 29 years with BASF.

BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the publication of research describing the use of HEPATOPAC® cultures with a targeted in vitro assay to identify small molecule drugs with high potential for drug-induced liver injury (DILI).

CCS Medical, Inc. (“CCS” or the “Company”), one of the nation’s leading providers of home medical supplies and services for patients with chronic conditions, announced today that the Company has named Tony Vahedian as Chief Executive Officer.

Vitro Diagnostics, Inc. announced the revocation of its SEC registration for Vitro Diagnostics, Inc while also announcing its plans for re-registration with the SEC.

CrossBay Medical, Inc., a health technology company focused on improving the delivery of women’s healthcare, announced it has received clearance from the Food and Drug Administration (FDA) to market its CrossGlide™ ETS Plus. Similar to the CrossGlide ETS, Endometrial Tissue Sampler (which received FDA clearance this summer), the ETS Plus also enables medical providers to perform a frictionless, office-based endometr

Influenza A Lab Results Come on Heels of Similar Findings of ClōSYS on the COVID-19 Virus, Just as U.S. Gears Up for Uncertain Flu and Cold Season [13-October-2020] SCOTTSDALE, Ariz. , Oct. 13, 2020 /PRNewswire/ -- Rowpar Pharmaceuticals, Inc., the makers of the ClōSYS brand of toothpastes, mouthwashes and oral sprays, announced today that an in vitro laboratory ana

- Real-world study shows the effectiveness and safety of second-line Gilotrif® (afatinib) tablets following first-line immunotherapy plus chemotherapy in the treatment of squamous cell carcinoma of the lung - Separate data presented indicate afatinib activity in TKI-naïve patients with G719X/L861Q/S768I non-resistant EGFR mutation-positive NSCLC [13-October-2020]

- BioNJ has released its final speaker roster featuring thought leaders from more than 20 leading biopharmaceutical organizations -- for its Eighth Annual C-Suite Summit, taking place virtually October 30 and November 6 .